Observational Database on Deep Brain Stimulation in Tourette Syndrome
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jun 23, 2020
Trial Information
Current as of September 10, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of deep brain stimulation (DBS) on individuals with Tourette syndrome, a condition that causes involuntary movements and sounds called tics. The researchers at Pitié-Salpêtrière Hospital in Paris are looking for patients who have severe Tourette syndrome that hasn’t responded to other treatments. If you’re eligible, you need to be willing to participate and be part of the French social security system.
Participants in the trial will be evaluated before the surgery and then once a year for five years after the DBS procedure. The study will look at how the treatment affects tic severity, any related mental health issues, overall quality of life, and cognitive functions. This information will help researchers understand how effective DBS is for people with Tourette syndrome and how it can improve their daily lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Tourette syndrome severe and drug-resistant eligible for bilateral deep brain stimulation
- • Person who voluntarily and knowledgeably agreed to participate in the study
- Exclusion Criteria:
- • Non affiliation to a French social security system (recipient or assign) excluding AME
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials